Login
$MLAB
$131.32 +$2.07 (1.6%) Close

Ownership

13F as of Q2 2026 · 5.6M shares outstanding

Who owns MLAB?

By type of holder
Institutions 89.5% Insiders 3.7% Everyone else 6.8%
Concentration Top 10 holders own 42.4%
Long Path Partners LP 8.5% · BlackRock, Inc. 7.9%
Institutional ownership
89.5%
+3.6 pts vs last qtr
Institutional holders
158
-2 vs last qtr
Net shares bought
+203.6K
by institutions in Q2 2026
New / sold out
20 / 22
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Jacobs Levy Equity Management, Inc +86.4K
  • FMR LLC +82.4K

Sign up to see all 5.

Biggest sellers in Q2 2026
  • Select Equity Group, L.P. SOLD OUT −235.9K
  • Roubaix Capital, LLC SOLD OUT −72.1K

Sign up to see all 5.

Who is planning to sell?

Notices of proposed sale, last 12 months
$6.14M
7 notices from 3 people
Shares covered
51.8K
0.93% of the company
Arranged in advance
0%
of the value is under a 10b5-1 plan
Under a 10b5-1 plan No plan
$0$2.5M$5.1MNovDecJanFebMarAprMayJun 2026: $1.1M without a planJunJulAug 2026: $5.1M without a planAugSepOct
Largest proposed sellers
  • Owens Gary M Former officer $5.43M
  • Sakys John Officer $377K

Sign up to see all 3.

Every notice on Red Flags →

A Form 144 is notice of a planned sale, not the sale itself. What insiders actually sold is on Insider Transactions.

Is your stake being diluted?

Diluted share count, FY2017–FY2026
+44.8%
+4.20% a year
Each share's claim on the business
−30.9%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $89M
over 10 fiscal years
Diluted shares, split-adjusted
3.7M4.6M5.6M2017: 3.8M shares'172018: 3.8M shares'182019: 4.0M shares'192020: 4.4M shares'202021: 5.1M shares'212022: 5.3M shares'222023: 5.4M shares'232024: 5.4M shares'242025: 5.4M shares'252026: 5.6M shares'26
Buybacks Stock-based comp
$0$8.9M$17.9M2017 buybacks: $02017 stock comp: $1.4M'172018 buybacks: $02018 stock comp: $1.7M'182019 buybacks: $02019 stock comp: $4.2M'192020 buybacks: $02020 stock comp: $5.5M'202021 buybacks: $02021 stock comp: $9.3M'212022 buybacks: $02022 stock comp: $11.4M'222023 buybacks: $02023 stock comp: $12.5M'232024 buybacks: $02024 stock comp: $11.9M'242025 buybacks: $02025 stock comp: $13.1M'252026 buybacks: $02026 stock comp: $17.9M'26

How patient are the owners?

Institutional shares by how long they've been held
5+ years47% 3–5 years7% 1–3 years20% Under 1 year25%
Quarterly turnover
16.2%
of institutional shares changed hands
Top 10 managers, median time held
5 years

Super Investors

Investment managers reporting MLAB on Form 13F
LP
Long Path Partners LP
Shares
477.1K
% of company
8.53%
Change vs last qtr
+71.5K (+17.6%)
Held since
Q4 '25
B
BlackRock, Inc.
Shares
440.6K
% of company
7.87%
Change vs last qtr
+46.7K (+11.9%)
Held since
≤2021

28 more super investors behind a free account

See every manager holding Mesa Laboratories, Inc., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting MLAB on Form N-PORT; together they hold 33.8% of the company
VT
Position value
$16.8M
% of company
3.01%
% of the fund
0.00%
As of
June 30, 2026
IR
iShares Trust
Position value
$13.8M
% of company
2.48%
% of the fund
0.02%
As of
June 30, 2026

23 more funds behind a free account

See every fund holding Mesa Laboratories, Inc. and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
SJ
Sullivan John James
Insider
Shares
65.7K
% of company
1.17%
Change vs last qtr
—
Held since
—
OG
Owens Gary M
Insider
Shares
64.1K
% of company
1.15%
Change vs last qtr
—
Held since
—

9 more holders behind a free account

See every insider and 5%+ holder of Mesa Laboratories, Inc..

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support